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Abstract
Background: Advanced head and neck squamous cell carcinomas frequently develop distant metastases to limited
organs, including the lungs, bone, mediastinal lymph nodes, brain, and liver. Peritoneal carcinomatosis as an initial
distant metastasis from hypopharyngeal squamous cell carcinoma is quite rare.
Case presentation: A 75-year-old man diagnosed with hypopharyngeal squamous cell carcinoma and his
clinical stage was determined as T2N2cM0. Notably, the right retropharyngeal lymph node surrounded more
than half of the right internal carotid artery. Concomitant conformal radiation therapy was administered for
the primary hypopharyngeal lesion, and the whole neck and tumor response was evaluated at this point
according to our algorithm-based chemoradioselection protocol. As the tumor responses at both the primary
and lymph nodes were poor, with the right retropharyngeal lymph node in particular demonstrating mild
enlargement, we performed a radical surgery: pharyngolaryngectomy, bilateral neck dissection, and
reconstruction of the cervical esophagus with a free jejunal flap. Then, postoperative CRT was performed.
During these therapies, the patient developed a fever and mild abdominal pain, which was associated with
an increased C-reactive protein level. Contrast-enhanced computed tomography from the neck to the pelvis
demonstrated mild peritoneal hypertrophy and ascites with no evidence of recurrent and/or metastatic tumor
formation. We initially diagnosed acute abdomen symptoms as postoperative ileus. However, cytological
examination of the refractory ascites resulted in a diagnosis of peritoneal carcinomatosis. Owing to rapid
disease progress, the patient died 1.5 months after abdominal symptom onset.
Conclusions: The present case is the second reported case of head and neck squamous cell carcinoma with
peritoneal carcinomatosis as an incipient distant metastasis. Therefore, peritoneal carcinomatosis should be
considered a differential diagnosis when acute abdomen is noted during treatment for head and neck
cancers.
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Background
Reported rates of distant metastases (DMs) observed
in patients with head and neck squamous cell carcin-
oma (HNSCC) is 8.5 %. In a large-scale study of
HNSCC (n = 2550), Spector et al. found DMs in 16.3 %
of patients with hypopharyngeal carcinoma [1]. Because
nearly 100 % of DMs from HNSCCs arise in relatively lim-
ited organs: the lungs (77 %), bone (19 %), mediastinal/
other lymph nodes (4 %), as well as the brain, liver, and
skin, it is quite rare to encounter DMs at other sites [1].
We recently encountered a case of hypopharyngeal carcin-
oma that showed peritoneal metastasis (PM) as an initial
DM. Based on an English language medical literature
PubMed search, this appears to be the second reported
case of such a condition. Herein, we present and discuss
the clinical course of the patient with a review of medical
references and medical charts of our institute.
Case presentation
In 2014, a 75-year-old man was referred to our depart-
ment with bilateral swelling of the cervical lymph nodes.
There was moderately differentiated SCC in the poster-
ior wall of the hypopharynx. After an extent-of-disease
workup, his clinical stage was determined as T2N2cM0.
Notably, the right retropharyngeal lymph node
surrounded more than half of the right internal carotid
artery. Initially, 41.4 Gy of concomitant conformal radi-
ation therapy (CRT; 1.8 Gy/fr, 5 fr/week + cisplatin
80 mg/m2, on day 1) was administered for the primary
hypopharyngeal lesion, and the whole neck and tumor
response was evaluated at this point according to our
algorithm-based chemoradioselection protocol [2].
As the tumor responses at both the primary and
lymph nodes were poor, with the right retropharyngeal
lymph node in particular demonstrating mild enlarge-
ment, we performed a radical surgery: pharyngolaryn-
gectomy, bilateral neck dissection (rt.: Ib-V, lt.: Ib-V),
and reconstruction of the cervical esophagus with a free
jejunal flap. Owing to the severe adhesion of the lymph
nodes, the left internal jugular vein and the left spinal
accessory nerve were sacrificed.
Pathological examination revealed pT2pN2c with
extra-capsular spread of the lymph nodes. Postoperative
CRT was started on postoperative day 21. However, dur-
ing CRT, cystic lesions appeared around the anterior
edge of the left lower trapezius muscle (i.e., posterolat-
eral area of the dissected level V), and fine-needle aspir-
ation cytology revealed a class IV finding. We then
surgically removed the tumor, which was a recurrent
lymph node. On day 10 following reoperation, the pa-
tient developed a fever and mild abdominal pain, which
was associated with an increased C-reactive protein
level. Contrast-enhanced computed tomography from
the neck to the pelvis demonstrated mild peritoneal
hypertrophy and ascites compared to the preoperative
images (Fig. 1a–d) with no evidence of recurrent and/or
metastatic tumor formation.
Assuming postoperative ileus, the patient was asked to
fast and was treated with an antibiotic. However, no im-
provement in laboratory, imaging, or clinical findings
was obtained. On day 20 after reoperation, the result of
an ascites test was suggestive of SCC. For a more accur-
ate diagnosis, cellblocks were made using recollected
peritoneal fluid. Cytological examination revealed that
tumor cells were immunopositive for p40 (a highly
specific squamous cell carcinoma marker) and CK5/6
(epithelial markers; Fig. 2a–c) [3]. These findings, to-
gether with his clinical course, indicated the development
Fig. 1 Computed tomography imaging showed the influence of peritoneal carcinomatosis. a The abdominal CT image before the abdominal
surgery represents no findings of ascites. b The abdominal CT image before the abdominal surgery represents no findings of peritonitis. c
Rectovesical excavation. d Arrow heads indicate hypertrophy and increasing fat brightness of the peritoneum. CT computed tomography
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of PM from hypopharyngeal squamous cell carcinoma.
Considering the patient’s rapidly deteriorating general
condition, the best supportive care was chosen. However,
the patient died 1.5 months following the onset of periton-
itis symptoms.
Discussion
PM often results from cancers of peritoneal organs, in-
cluding gastric cancer, colon cancer, pancreatic/biliary
cancer, ovarian cancer, and uterine cancer [4]. As a result,
almost all cases of PMs are adenocarcinomas. Only a few
cases of SCC-origin PMs, derived from the esophagus,
uterus, and ovaries, have been reported [5–7].
We reviewed medical charts of HNSCC patients
treated at our institute from January 1995 until June
2015 and found that 258 patients developed DMs. Other
than the present case, only one additional patient mani-
fested PM. In the prior case, PM occurred 2 years after
initial treatment in association with concomitant pul-
monary, bone, and skin metastasis. In contrast, the
present case developed PM as an initial DM from hypo-
pharyngeal squamous cell carcinoma.
A PubMed search revealed three reported cases of PM
from HNSCC [8, 9]. Wong et al. reported a case in
which PM occurred following chemoradiotherapy for
hypopharyngeal carcinoma [8]. In addition, Hsu et al. re-
ported two cases, both of which were associated with
multiple DMs to other organs [9]. Thus, the present
study appears to be the fourth reported case of PM from
HNSCC and the second reported case of PM occurring
as an initial metastasis from HNSCC.
In the previously reported cases, after the onset of peri-
toneal carcinomatosis, the prognoses of the patients were
very poor, ranging from a few days to a few months [8, 9].
In the present case, the patient also demonstrated
unfavorable progress and died 1.5 months following the
onset of acute abdomen. In general, malignant ascites and
PM progress rapidly. However, in selected cases of
gastrointestinal and gynecologic adenocarcinomas,
chemotherapy and peritoneal excision can improve
quality of life and provide a survival benefit [10, 11]. In
addition, cell-free and concentrated ascites reinfusion
therapy is efficacious for treating intractable ascites, be-
cause it relieves abdominal symptoms and maintains
plasma osmolality, thus sparing the frequent removal of
large volumes of peritoneal fluid [12]. However, because
of the rapid disease progression in the present case,
these options were not feasible. In any case, the estab-
lishment of effective treatment modalities for patients
with PM from HNSCC, which progresses extremely
rapidly, is an urgent task.
We initially misdiagnosed the patient’s condition as post-
operative ileus, mainly because it is not uncommon for pa-
tients to develop ileus following the harvest of a free jejunal
flap and because there was no evidence of tumor formation
in the peritoneum or pelvis. However, the cell block-based
peritoneal fluid cytology test led to the diagnosis of PM,
sparing invasive procedures (e.g., laparotomy). Therefore,
when encountering a refractory acute abdomen during and
after treatment for HNSCC, it is essential to consider the
possibility of PM and conduct an ascites test, despite no ap-
parent tumor in the abdominal cavity.
Fig. 2 Cytological microscopic imaging of peritoneal fluid (cell blocks). a Hematoxylin-eosin stain showed isolated atypical cells with nucleoli
distinct within the nucleus (arrowhead). b Immunohistochemistry for p40, a highly specific squamous cell carcinoma marker, was positive in the
nucleus. c Immunohistochemistry for CK5/6, epithelial markers, was positive in the cytoplasm. H.E. hematoxylin-eosin
Wakasaki et al. World Journal of Surgical Oncology  (2016) 14:265 Page 3 of 4
Given that the present case underwent cervical and ab-
dominal surgery simultaneously, it is possible that iatro-
genic plantation of cancer might be the cause of PM.
However, in our institute, the surgical field and instru-
ments are strictly separated to avoid cross-contamination.
This principle has worked well thus far, and we have never
encountered any cross-contamination-related condition
considering our 79 cases of free jejunal flap reconstruction
performed during the last decade. Therefore, we assume
that iatrogenic transplantation is not the cause of PM in
the present case.
Reported risk factors for distant metastasis of HNSCC
include extracapsular invasion in the neck, advanced
lymph node metastasis (N2, N3), a long period of lymph
node metastasis, spread of lymph node metastasis to the
lower neck, advanced primary lesion, and absence of
local control [13]. Notably, the present case met all these
criteria, suggesting a high metastatic potential of the
tumor cells. This may partly explain the unusual meta-
static pattern seen in the present case.
Conclusions
We reported herein an extremely rare case of hypophar-
yngeal carcinoma, which demonstrated PM as an incipi-
ent metastasis during curative treatment. Although rare,
PM should be considered when ascites or peritonitis oc-
curs during or after treatment for HNSCC.
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